Brain Arteriovenous Malformations Clinical Trial
— MAV-IRMOfficial title:
Interest of New MRI Sequences After Embolization of Brain Arteriovenous Malformations (MAV-IRM)
In previous studies exploring specific sequences of MRI (susceptibility weighted imaging (SWI) and arterial spin labeling (ASL)), the investigators have shown the great sensibility of these MRI sequences to detect arteriovenous shunts, compared to angiography imaging (static or dynamic). This prospective study aims to compare multisequence MRI to brain arteriography imaging in patients undergoing brain arteriovenous malformations embolization.
| Status | Recruiting |
| Enrollment | 75 |
| Est. completion date | February 1, 2025 |
| Est. primary completion date | February 1, 2025 |
| Accepts healthy volunteers | No |
| Gender | All |
| Age group | 18 Years and older |
| Eligibility | Inclusion Criteria: - Patient = 18 years old - with brain Arteriovenous Malformations - embolization treatment scheduled Exclusion Criteria: - patient's refusal to participate in the study - contraindication to undergo MRI examination - patient under legal protection |
| Country | Name | City | State |
|---|---|---|---|
| France | Fondation Opthalmologique A de Rothschild | Paris |
| Lead Sponsor | Collaborator |
|---|---|
| Fondation Ophtalmologique Adolphe de Rothschild |
France,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | sensitivity of multisequence MRI to detect a residual arteriovenous malformation after embolization | within 3 months after embolization |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05449106 -
Evaluation of Clinical Outcomes of Unruptured bAVMs Treated With Medical Management Alone Based on Multimodal CT
|
||
| Completed |
NCT00857662 -
Study Comparing Onyx and TRUFILL in Brain Arteriovenous Malformations (AVMs)
|
Phase 2 |